Interpretation

Half-life vs duration

People often use half-life as shorthand for how long something "lasts." It is an understandable shortcut, especially when the number is easy to find and the lived experience is harder to describe. But half-life and duration are different kinds of information.

Half-life is pharmacokinetic: it describes concentration decline under a model. Duration is usually pharmacodynamic: it reflects what the substance does to the body and what a person notices over time. Merck Manual separates those ideas plainly: pharmacokinetics is what the body does to a drug, while pharmacodynamics is what the drug does to the body.

Why effects can end before elimination

A person may stop noticing the main effect while a measurable amount remains. That can happen because the concentration has fallen below an effect threshold, because the body has adapted during the experience, or because the most noticeable phase was driven by absorption and peak concentration rather than by the slow tail of elimination.

This is why a HalfLifeDB chart should not be read as a feeling-meter. When the curve shows that a fraction remains, it is describing the model output, not the intensity of an experience.

Why effects can outlast the parent compound

The reverse can also happen. Some substances form active metabolites with their own timelines. Some effects involve downstream biology that continues after parent-compound concentrations have dropped. Sleep loss, anxiety, sedation, cardiovascular strain, or rebound symptoms can also shape how long the episode feels.

FDA labeling guidance highlights why clinical pharmacology summaries often discuss absorption, distribution, metabolism, excretion, specific populations, and interactions together. Half-life is one important piece, but it sits inside a larger story.

This is also why a careful article should avoid turning a published half-life into a promise about how a person will feel. The concentration-time curve can be measured in plasma, blood, urine, or another matrix, while the outcome a reader cares about may involve the brain, sleep, movement, attention, anxiety, pain, or another clinical endpoint entirely.

Four different clocks

• Measured concentration: what a sample or model says is present over time.
• Felt duration: when the main subjective or noticeable effect seems to begin and end.
• Functional impairment: a safety-sensitive question that cannot be answered from half-life alone.
• Detection window: a testing question shaped by analytes, thresholds, specimen type, and lab method.

How HalfLifeDB uses the distinction

HalfLifeDB uses one half-life value to illustrate exponential decline. It is best for comparing short and long half-life estimates, seeing why a tail can remain after the main effect is gone, and understanding why repeated exposure can overlap. It is not designed to estimate subjective duration, impairment, safety, or test outcomes.